We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $109M
1-Year Est. Return 97.13%
This Fund
S&P 500
This Quarter Est. Return
+34.11%
1 Year Est. Return
+97.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
+$6.53M
Cap. Flow
-$6.26M
Cap. Flow %
-5.72%
Top 10 Hldgs %
32.08%
Holding
212
New
75
Increased
28
Reduced
43
Closed
29

Top Buys

Rank Stock Value
1
NOMD icon
Nomad Foods
NOMD
+$1.34M
2
MLAA
Mountain Lake Acquisition Corp II
MLAA
+$1.27M
3
DSGR icon
Distribution Solutions Group
DSGR
+$1.26M
4
ENGN icon
enGene Therapeutics
ENGN
+$1.24M
5
ABVX
Abivax
ABVX
+$1.02M

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$8.47M
2
LEG
Leggett & Platt
LEG
+$2.1M
3
ICLR icon
Icon
ICLR
+$1.96M
4
KZR
Kezar Life Sciences
KZR
+$1.8M
5
MCW
Mister Car Wash
MCW
+$1.54M

Sector Composition

Rank Sector Weight
1 Healthcare 27.11%
2 Consumer Discretionary 14.33%
3 Financials 12.51%
4 Miscellaneous 10.11%
5 Real Estate 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DRVN icon
1
Driven Brands
DRVN
$2B
$7.22M 6.6%
518,246
-107,254
-17% -$1.41M
RVMDW icon
2
Revolution Medicines Inc Warrant
RVMDW
$119M
$4.68M 4.28%
+25,000
New +$135K
PRTA icon
3
Prothena Corp
PRTA
$452M
$4.09M 3.73%
417,270
-32,190
-7% -$318K
SEG
4
Seaport Entertainment Group
SEG
$329M
$4.08M 3.73%
153,517
– –
GRND icon
5
Grindr
GRND
$2.69B
$3.16M 2.89%
220,000
-14,000
-6% -$181K
STHO icon
6
Star Holdings Shares of Beneficial Interest
STHO
$114M
$2.96M 2.71%
324,408
+50,336
+18% +$435K
FLL icon
7
Full House Resorts
FLL
$75.1M
$2.58M 2.36%
925,578
+10,000
+1% +$26.4K
ABUS icon
8
Arbutus Biopharma
ABUS
$1.02B
$2.4M 2.19%
500,000
– –
TRIP icon
9
TripAdvisor
TRIP
$1.04B
$2.08M 1.9%
152,000
-38,000
-20% -$430K
ECHO
10
EchoStar
ECHO
$26.9B
$1.85M 1.69%
17,800
-200
-1% -$24.4K
ABVX
11
Abivax
ABVX
$10.2B
$1.73M 1.58%
13,000
+9,000
+225% +$1.02M
GDOT icon
12
Green Dot
GDOT
$760M
$1.72M 1.57%
127,594
-35,138
-22% -$440K
DSGR icon
13
Distribution Solutions Group
DSGR
$1.61B
$1.72M 1.57%
63,000
+46,143
+274% +$1.26M
TBPH icon
14
Theravance Biopharma
TBPH
$884M
$1.69M 1.55%
99,500
-3,500
-3% -$57.9K
RLYB icon
15
Rallybio
RLYB
$88.7M
$1.68M 1.53%
104,850
+74,720
+248% +$961K
ONL
16
Orion Office REIT
ONL
$147M
$1.67M 1.53%
578,567
-336,433
-37% -$921K
MNRO icon
17
Monro
MNRO
$394M
$1.65M 1.51%
96,500
+44,156
+84% +$723K
RVMD icon
18
Revolution Medicines
RVMD
$43.2B
$1.63M 1.49%
8,700
-58,000
-87% -$8.47M
BHF icon
19
Brighthouse Financial
BHF
$2.87B
$1.58M 1.45%
25,000
– –
JANX icon
20
Janux Therapeutics
JANX
$1.04B
$1.5M 1.37%
97,978
-24,522
-20% -$355K
NOMD icon
21
Nomad Foods
NOMD
$1.54B
$1.48M 1.35%
+135,000
New +$1.34M
ARVN icon
22
Arvinas
ARVN
$554M
$1.46M 1.33%
175,590
-48,400
-22% -$451K
DK icon
23
Delek US
DK
$4.72B
$1.37M 1.25%
27,000
-33,000
-55% -$1.46M
WBD icon
24
Warner Bros
WBD
$70.3B
$1.36M 1.24%
51,000
– –
ZIM icon
25
ZIM Integrated Shipping Services
ZIM
$3.56B
$1.35M 1.24%
52,000
-3,000
-5% -$77.4K
1
2 3 4 5

Similar funds

GCM
Gumshoe Capital Management New York $109M AUM
SSCM
Seven Six Capital Management New York $110M AUM 1.79% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $110M AUM
BWM
Briggs Wealth Management Glastonbury, Connecticut $110M AUM
QFMHK
Q Fund Management (Hong Kong) Hong Kong $110M AUM 1,372.85% 1-Year Est. Return
AC
Amitell Capital Singapore $109M AUM 50.64% 1-Year Est. Return
ANBOT
American National Bank of Texas Richardson, Texas $110M AUM 17.16% 1-Year Est. Return
SCA
Sensenig Capital Advisors Collegeville, Pennsylvania $109M AUM

Rangeley Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Rangeley Capital held 212 positions worth $109M, up 6.3% from $103M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Rangeley Capital withdrew a net $6.26M in Q2 2026, closing 29 positions and reducing 43 holdings. Its most notable exit was Leggett & Platt, an estimated $2.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Rangeley Capital opened a new position in Nomad Foods worth $1.48M.

  • Rangeley Capital's largest Q2 2026 buy was Nomad Foods: 135,000 shares worth $1.48M.
  • Rangeley Capital added most to Distribution Solutions Group in Q2 2026, an estimated $1.26M increase.
  • Rangeley Capital's biggest Q2 2026 reduction was Revolution Medicines, cutting an estimated $8.47M.
  • Rangeley Capital fully exited Leggett & Platt in Q2 2026, selling an estimated $2.1M.
  • Rangeley Capital's ten largest holdings make up 32% of its $109M portfolio in Q2 2026.
  • Rangeley Capital opened 75 new positions and closed 29 in Q2 2026.
  • Rangeley Capital's portfolio value rose 6.3% quarter-over-quarter to $109M.

Based on Rangeley Capital's 13F filing for Q2 2026, filed 14 Aug 2026.